Eagle Medical Llc | |
635 Florida Ave Nw, Washington, District Of Columbia 20001 | |
(202) 639-0250 |
Name | Eagle Medical Llc |
---|---|
Organization Name | Eagle Medical |
Location | 635 Florida Ave Nw, Washington, District Of Columbia 20001 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (202) 639-0250 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In Switzerland, between 7000 and 8000 persons fall ill with a campylobacter infection annually. This makes it the most frequent bacterial disease transmitted through food.
Seattle Genetics, Inc. today reported data from a phase I weekly-dosing clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), including multiple complete and partial remissions in patients with relapsed or refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma (ALCL).
New research from New Zealand has found that over-eating rather than lack of physical activity, is why Kiwis are pilling on the excess kilos.
The AIDS Clinical Trials Group, the largest global HIV research network, which has expanded its focus to include evaluating outpatient treatment for COVID-19, today announced positive data for the monoclonal antibody combination therapy BRII-196/BRII-198 from the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies.
Research reveals that 1 in 3 complementary medicine users do not disclose their CM use to their medical providers, posing significant direct and indirect risks of adverse effects and harm due to unsafe concurrent use of CM and conventional medicine use.
› Verified 5 days ago
NPI Number | 1396834321 |
Organization Name | EAGLE MEDICAL |
Doing Business As | EAGLE MEDICAL,LLC |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 635 Florida Ave Nw, Washington, DC 20001 |
Phone Number | 202-639-0250 |
News Archive
In Switzerland, between 7000 and 8000 persons fall ill with a campylobacter infection annually. This makes it the most frequent bacterial disease transmitted through food.
Seattle Genetics, Inc. today reported data from a phase I weekly-dosing clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), including multiple complete and partial remissions in patients with relapsed or refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma (ALCL).
New research from New Zealand has found that over-eating rather than lack of physical activity, is why Kiwis are pilling on the excess kilos.
The AIDS Clinical Trials Group, the largest global HIV research network, which has expanded its focus to include evaluating outpatient treatment for COVID-19, today announced positive data for the monoclonal antibody combination therapy BRII-196/BRII-198 from the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies.
Research reveals that 1 in 3 complementary medicine users do not disclose their CM use to their medical providers, posing significant direct and indirect risks of adverse effects and harm due to unsafe concurrent use of CM and conventional medicine use.
› Verified 5 days ago
News Archive
In Switzerland, between 7000 and 8000 persons fall ill with a campylobacter infection annually. This makes it the most frequent bacterial disease transmitted through food.
Seattle Genetics, Inc. today reported data from a phase I weekly-dosing clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), including multiple complete and partial remissions in patients with relapsed or refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma (ALCL).
New research from New Zealand has found that over-eating rather than lack of physical activity, is why Kiwis are pilling on the excess kilos.
The AIDS Clinical Trials Group, the largest global HIV research network, which has expanded its focus to include evaluating outpatient treatment for COVID-19, today announced positive data for the monoclonal antibody combination therapy BRII-196/BRII-198 from the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies.
Research reveals that 1 in 3 complementary medicine users do not disclose their CM use to their medical providers, posing significant direct and indirect risks of adverse effects and harm due to unsafe concurrent use of CM and conventional medicine use.
› Verified 5 days ago
We Work Office Building Type: Durable Medical Equipment & Medical Supplies Supplier Location: 80 M St Se, Washington, District Of Columbia 20003 Phone: (844) 417-8633 | |
Aids Healthcare Foundation Type: Pharmacy Location: 2141 K St Nw, Washington, District Of Columbia 20037 Phone: (202) 293-8695 | |
All N 1 Medical Supplies & Treasure Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3811 Minnesota Ave Ne, Washington, District Of Columbia 20019 Phone: (202) 388-3300 | |
Bellevue Pharmacy Type: Community/Retail Pharmacy Location: 3939 S Capitol St Sw, Washington, District Of Columbia 20032 Phone: (202) 623-4221 | |
Capitol Medical Supply Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1618 7th St Nw, Washington, District Of Columbia 20001 Phone: (202) 667-1097 |